1
|
Martorell A, Santos-Alarcón S, Sahuquillo-Torralba A, Rivera-Díaz R, Belinchón-Romero I, Ruiz-Genao D, Romero-Maté A, Ruiz-Villaverde R, Ferran-Farrés M, Gallardo-Hernández F, Almenara-Blasco M, Suarez-Perez JA, González-Cantero Á, Martínez-Lorenzo E, Fernández-Armenteros JM, Del Alcázar-Viladomiu E, García-Latasa J, Rocamora-Durant V, Ara-Martín M, Mateu-Puchades A, Llamas-Velasco M, Vilarrasa E, Velasco-Pastor M, De la Cueva P, Carrascosa JM, Magdaleno-Tapial J. Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study. Actas Dermosifiliogr 2024:S0001-7310(24)00187-X. [PMID: 38452889 DOI: 10.1016/j.ad.2024.02.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2024] [Accepted: 02/24/2024] [Indexed: 03/09/2024] Open
Abstract
BACKGROUND AND OBJECTIVE Risankizumab - a humanized monoclonal antibody that targets the p19 subunit of IL-23 - has been recently approved to treat moderate-to-severe plaque psoriasis. Real-world data based on a representative pool of patients are currently lacking. OBJECTIVE To assess the mid- and long-term safety and efficacy profile of risankizumab in patients with moderate-to-severe psoriasis in the routine clinical practice. METHODS This was a retrospective and multicenter study of consecutive psoriatic patients on risankizumab from April 2020 through November 2022. The primary endpoint was the number of patients who achieved a 100% improvement in their Psoriasis Area and Severity Index (PASI) (PASI100) on week 52. RESULTS A total of 510 patients, 198 (38.8%) women and 312 (61.2%) men were included in the study. The mean age was 51.7±14.4 years. A total of 227 (44.5%) study participants were obese (body mass index [BMI] >30kg/m2). The mean baseline PASI score was 11.4±7.2, and the rate of patients who achieved PASI100 on week 52, 67.0%. Throughout the study follow-up, 21%, 50.0%, 59.0%, and 66% of the patients achieved PASI100 on weeks 4, 16, 24, and 40, respectively. The number of patients who achieved a PASI ≤2 was greater in the group with a BMI ≤30kg/m2 on weeks 4 (P=.04), 16 (P=.001), and 52 (P=.002). A statistically significantly greater number of patients achieved PASI100 in the treatment-naïve group on weeks 16 and 52 (P=.001 each, respectively). On week 16 a significantly lower number of participants achieved PASI100 in the group with psoriatic arthropathy (P=.04). Among the overall study sample, 22 (4.3%) patients reported some type of adverse event and 20 (3.9%) discontinued treatment. CONCLUSIONS Risankizumab proved to be a safe and effective therapy for patients with moderate-to-severe psoriasis in the routine clinical practice.
Collapse
Affiliation(s)
- A Martorell
- Department of Dermatology, Hospital de Manises, Valencia, Spain.
| | - S Santos-Alarcón
- Department of Dermatology, Hospital Virgen de los Lirios, Alcoy, Alicante, Spain
| | - A Sahuquillo-Torralba
- Department of Dermatology, Hospital General Universitario Dr. Balmis-ISABIAL-UMH, Alicante, Spain
| | - R Rivera-Díaz
- Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - I Belinchón-Romero
- Department of Dermatology, Hospital General Universitario Dr. Balmis-ISABIAL-UMH, Alicante, Spain
| | - D Ruiz-Genao
- Department of Dermatology, Hospital Universitario de Alcorcón, Madrid, Spain
| | - A Romero-Maté
- Department of Dermatology, Hospital Universitario de Fuenlabrada, Madrid, Spain
| | - R Ruiz-Villaverde
- Department of Dermatology, Hospital Universitario PTS, Granada, Spain
| | - M Ferran-Farrés
- Department of Dermatology, Hospital del Mar, Barcelona, Spain
| | | | - M Almenara-Blasco
- Department of Dermatology, Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - J A Suarez-Perez
- Department of Dermatology, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain
| | - Á González-Cantero
- Department of Dermatology, Hospital Universitario Ramón y Cajal, Madrid, Spain; Faculty of Medicine, Universidad Francisco de Vitoria, Madrid, Spain
| | | | | | | | - J García-Latasa
- Department of Dermatology, Hospital Royo Villanova, Zaragoza, Spain
| | | | - M Ara-Martín
- Department of Dermatology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
| | - A Mateu-Puchades
- Department of Dermatology, Hospital Universitario Doctor Peset, Valencia, Spain
| | - M Llamas-Velasco
- Department of Dermatology, Hospital de la Princesa, Madrid, Spain
| | - E Vilarrasa
- Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | | | - P De la Cueva
- Department of Dermatology, Hospital Universitario Infanta Leonor, Madrid, Spain
| | - J M Carrascosa
- Department of Dermatology, Hospital Universitari Germans Trias i Pujol, UAB, IGTP, Badalona, Barcelona, Spain
| | - J Magdaleno-Tapial
- Department of Dermatology, Hospital General Universitario de Valencia, Valencia, Spain
| |
Collapse
|
2
|
Reolid A, Armesto S, Sahuquillo-Torralba A, Torres T, Feltes R, Vilarrasa E, Belinchón I, de la Cueva P, Rodríguez L, Romero-Maté A, Vidal D, Coto-Segura P, Herrera-Acosta E, Riera-Monroig J, Salgado L, Llamas-Velasco M, Daudén E. Secukinumab is effective and safe in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting. J Am Acad Dermatol 2022; 87:705-709. [PMID: 35640798 DOI: 10.1016/j.jaad.2022.05.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2021] [Revised: 05/02/2022] [Accepted: 05/05/2022] [Indexed: 11/24/2022]
Affiliation(s)
- A Reolid
- Hospital Universitario de la Princesa (Madrid, Spain)
| | - S Armesto
- Hospital Universitario Marqués de Valdecilla (Santander, Spain)
| | - A Sahuquillo-Torralba
- Hospital Universitario y Politécnico La Fe, Instituto de Investigación Sanitária La Fe (Valencia, Spain)
| | - T Torres
- Department of Dermatology, Centro Hospitalar Universitário do Porto (Porto, Portugal)
| | - R Feltes
- Hospital Universitario la Paz (Madrid, Spain)
| | - E Vilarrasa
- Hospital de la Santa Creu i Sant Pau (Barcelona, Spain)
| | - I Belinchón
- Hospital General Universitario de Alicante - ISABIAL (Alicante, Spain)
| | - P de la Cueva
- Hospital Universitario Infanta Leonor (Madrid, Spain)
| | - L Rodríguez
- Hospital Universitario Virgen del Rocío (Sevilla, Spain)
| | | | - D Vidal
- Hospital de Sant Joan Despí Moisés Broggi (Barcelona, Spain)
| | - P Coto-Segura
- Hospital Vital Alvarez-Buylla de Mieres (Asturias, Spain)
| | | | | | - L Salgado
- Complejo Hospitalario Universitario (Pontevedra, Spain)
| | | | - E Daudén
- Hospital Universitario de la Princesa (Madrid, Spain)
| |
Collapse
|
3
|
Utrera-Busquets M, Romero-Maté A, Castaño Á, Alegre L, García-Donoso C, Borbujo J. Severe hidradenitis suppurativa complicated by renal AA amyloidosis. Clin Exp Dermatol 2015. [DOI: 10.1111/ced.12731] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- M. Utrera-Busquets
- Department of Dermatology; Hospital Universitario de Fuenlabrada; Fuenlabrada Madrid Spain
| | - A. Romero-Maté
- Department of Dermatology; Hospital Universitario de Fuenlabrada; Fuenlabrada Madrid Spain
| | - Á. Castaño
- Department of Pathology; Hospital Universitario de Fuenlabrada; Fuenlabrada Madrid Spain
| | - L. Alegre
- Department of Nephrology; Hospital Universitario de Fuenlabrada; Fuenlabrada Madrid Spain
| | - C. García-Donoso
- Department of Dermatology; Hospital Universitario de Fuenlabrada; Fuenlabrada Madrid Spain
| | - J. Borbujo
- Department of Dermatology; Hospital Universitario de Fuenlabrada; Fuenlabrada Madrid Spain
| |
Collapse
|
4
|
Gomez-Barroso D, Herrador Z, San Martín JV, Gherasim A, Aguado M, Romero-Maté A, Molina L, Aparicio P, Benito A. Spatial distribution and cluster analysis of a leishmaniasis outbreak in the south-western Madrid region, Spain, September 2009 to April 2013. Euro Surveill 2015; 20:11-20. [DOI: 10.2807/1560-7917.es2015.20.7.21037] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Binary file ES_Abstracts_Final_ECDC.txt matches
Collapse
Affiliation(s)
- D Gomez-Barroso
- Network Biomedical Research Centre in Epidemiology and Public Health (CIBERESP in Spanish), Madrid, Spain
- These authors contributed equally to this article
- Health Institute Carlos III (ISCIII), Madrid, Spain
| | - Z Herrador
- Network Biomedical Research on Tropical Diseases (RICET in Spanish), Madrid, Spain
- National Centre for Tropical Medicine, ISCIII, Madrid, Spain
- These authors contributed equally to this article
| | - J V San Martín
- Fuenlabrada University Hospital, Madrid, Spain
- Network Biomedical Research on Tropical Diseases (RICET in Spanish), Madrid, Spain
| | - A Gherasim
- National Centre for Tropical Medicine, ISCIII, Madrid, Spain
| | - M Aguado
- Fuenlabrada University Hospital, Madrid, Spain
| | | | - L Molina
- Fuenlabrada University Hospital, Madrid, Spain
| | - P Aparicio
- Network Biomedical Research on Tropical Diseases (RICET in Spanish), Madrid, Spain
- National Centre for Tropical Medicine, ISCIII, Madrid, Spain
| | - A Benito
- National Centre for Tropical Medicine, ISCIII, Madrid, Spain
- Network Biomedical Research on Tropical Diseases (RICET in Spanish), Madrid, Spain
| |
Collapse
|
5
|
Calderón-Komáromy A, Romero-Maté A, Moreno A. Large Hyperpigmented Macule on the Leg of an Adolescent Girl. Actas Dermo-Sifiliográficas (English Edition) 2014. [DOI: 10.1016/j.adengl.2014.09.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
6
|
Affiliation(s)
- H. Álvarez-Garrido
- Department of Dermatology; Hospital Universitario de Fuenlabrada; Madrid Spain
| | - J. C. Tardío
- Department of Pathology; Hospital Universitario de Fuenlabrada; Madrid Spain
| | - A. Romero-Maté
- Department of Dermatology; Hospital Universitario de Fuenlabrada; Madrid Spain
| | - J. Borbujo
- Department of Dermatology; Hospital Universitario de Fuenlabrada; Madrid Spain
| |
Collapse
|
7
|
Calderón-Komáromy A, Romero-Maté A, Moreno A. Large hyperpigmented macule on the leg of an adolescent girl. Actas Dermosifiliogr 2014; 105:867-8. [PMID: 24860918 DOI: 10.1016/j.ad.2014.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2013] [Revised: 03/04/2014] [Accepted: 03/09/2014] [Indexed: 11/28/2022] Open
Affiliation(s)
- A Calderón-Komáromy
- Servicio de Dermatología, Hospital Universitario de Fuenlabrada, Madrid, España.
| | - A Romero-Maté
- Servicio de Dermatología, Hospital Universitario de Fuenlabrada, Madrid, España
| | - A Moreno
- Servicio de Anatomía Patológica, Hospital Universitario de Fuenlabrada, Madrid, España
| |
Collapse
|
8
|
Navarro R, Vilarrasa E, Herranz P, Puig L, Bordas X, Carrascosa JM, Taberner R, Ferrán M, García-Bustinduy M, Romero-Maté A, Pedragosa R, García-Diez A, Daudén E. Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting. Br J Dermatol 2013; 168:609-16. [PMID: 22985451 DOI: 10.1111/bjd.12045] [Citation(s) in RCA: 75] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
BACKGROUND Both the safety and efficacy of biologic therapy may be affected in the presence of highly prevalent chronic viral hepatitis. OBJECTIVE To evaluate the safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and concomitant chronic viral hepatitis. METHODS This was a retrospective, multicentre study. Twenty-five patients with psoriasis and concurrent hepatitis C virus (HCV) (20 patients) or hepatitis B virus (HBV) (five patients) infection who had received at least one biologic agent (etanercept, 21 treatments; adalimumab, four; ustekinumab, four; infliximab, two) were included. Clinical, imaging and laboratory data were recorded. RESULTS In the case of HCV infection, the majority of the patients did not exhibit increases in their viral load or serum liver tests. Aspartate aminotransferase, alanine aminotransferase and gamma glutamyl transpeptidase were doubled from the baseline measurement in only one patient treated with etanercept. Two other cases exhibited viral load increases during the follow-up period. In total, 18 of the 26 treatments achieved a 75% improvement in their Psoriasis Area and Severity Index (PASI 75) score during the follow-up period. Two patients treated with etanercept were diagnosed with hepatocellular carcinoma. In the case of HBV infection, all of the patients were being treated with antiviral therapy, and none presented significant variations in viral load or serum liver enzymes. All patients achieved a PASI 75 during follow-up. CONCLUSIONS Biologic therapy was effective and safe for the majority of our patients with HCV and HBV infection, although there may be a risk of reactivation or aggravation. We describe the first cases to receive ustekinumab. The use of biologics should be limited to those cases in which the risk-benefit ratio is justified.
Collapse
Affiliation(s)
- R Navarro
- Department of Dermatology, Hospital Universitario de la Princesa, Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Aguado M, Espinosa P, Romero-Maté A, Tardío J, Córdoba S, Borbujo J. Brote de leishmaniasis cutánea en el municipio de Fuenlabrada. Actas Dermo-Sifiliográficas 2013. [DOI: 10.1016/j.ad.2012.11.005] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
10
|
Aguado M, Espinosa P, Romero-Maté A, Tardío JC, Córdoba S, Borbujo J. Outbreak of cutaneous leishmaniasis in Fuenlabrada, Madrid. Actas Dermosifiliogr 2013; 104:334-42. [PMID: 23567452 DOI: 10.1016/j.adengl.2013.03.005] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2012] [Accepted: 11/17/2012] [Indexed: 11/26/2022] Open
Abstract
BACKGROUND Leishmaniasis, an endemic infection in Spain, is caused by protozoan parasites of the Leishmania genus. Between 2010 and 2012, there was an outbreak of cutaneous and visceral leishmaniasis in Fuenlabrada, Madrid. OBJECTIVES To describe the cases of cutaneous leishmaniasis diagnosed over a 17-month period at the dermatology department of Hospital de Fuenlabrada. MATERIAL AND METHODS We analyzed the epidemiological, clinical, histological, and microbiological features of each case and also evaluated the treatments administered and outcomes. RESULTS We studied 149 cases. The incidence of cutaneous leishmaniasis showed a peak in the age range between 46 and 60 years and was similar in men and women. At the time of consultation, the lesions had been present for between 2 and 6 months in the majority of patients. The most common clinical presentation was with erythematous plaques and papules without crusts (52% of cases). Lesions were most often located in sun-exposed areas and were multiple in 57% of patients. In 67% of cases, the histological study showed non-necrotizing granulomatous dermatitis with no evidence of parasites using conventional staining methods. Diagnosis was confirmed by polymerase chain reaction (PCR) in 98% of patients. In the remaining cases, the histological study revealed Leishman-Donovan bodies in the skin. Intralesional pentavalent antimonials were the most commonly used drugs (76% of cases) and produced satisfactory results. CONCLUSIONS We have presented a large series of cases of cutaneous leishmaniasis diagnosed in the context of an outbreak. Multiple papules were the most common clinical presentation, with histology that showed non-necrotizing granulomatous dermatitis with no evidence of parasites. PCR of skin samples was the test that most frequently provided the diagnosis.
Collapse
Affiliation(s)
- M Aguado
- Servicio de Dermatología, Hospital Universitario de Fuenlabrada, Madrid, Spain.
| | | | | | | | | | | |
Collapse
|
11
|
Meseguer-Yebra C, Martínez-Morán C, Romero-Maté A, Moreno A, Arias-Palomo D, Borbujo J. Joint destruction and presence of small papules on the palms and soles. Clin Exp Dermatol 2012; 37:450-2. [PMID: 22582916 DOI: 10.1111/j.1365-2230.2011.04163.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- C Meseguer-Yebra
- Department of Dermatology, Universitario de Fuenlabrada, Madrid, Spain.
| | | | | | | | | | | |
Collapse
|
12
|
Villanueva CA, Tardío JC, Romero-Maté A, Borbujo J. [Generalized eruptive multinucleate cell angiohistiocytoma in a pregnant woman: a case report and review of the literature]. Actas Dermosifiliogr 2012; 103:450-2. [PMID: 22341877 DOI: 10.1016/j.ad.2011.09.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2011] [Revised: 08/07/2011] [Accepted: 09/15/2011] [Indexed: 11/27/2022] Open
|
13
|
Martínez-Morán C, Espinosa-Lara P, Nájera L, Romero-Maté A, Córdoba S, Hernández-Núñez A, Borbujo J. Embolia Cutis Medicamentosa (Nicolau Syndrome) After Glatiramer Acetate Injection. Actas Dermo-Sifiliográficas (English Edition) 2011. [DOI: 10.1016/j.adengl.2011.11.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
14
|
Garrido-Ríos AA, Nájera-Botello L, Romero-Maté A, Martínez-Morán C, Meseguer-Yebra C, Nieto-Perea O. Asymptomatic facial papules and alopecia of the eyebrows. Clin Exp Dermatol 2011; 36:434-5. [PMID: 21564185 DOI: 10.1111/j.1365-2230.2010.03958.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- A A Garrido-Ríos
- Department of Dermatology, Hospital Universitario of Fuenlabrada, Madrid, Spain.
| | | | | | | | | | | |
Collapse
|
15
|
García-Donoso C, Romero-Maté A, Martínez-Morán C, Borbujo J. Foliculitis recurrente por Pseudomonas aeruginosa. An Pediatr (Barc) 2011; 74:208-9. [DOI: 10.1016/j.anpedi.2010.10.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2010] [Revised: 10/28/2010] [Accepted: 10/31/2010] [Indexed: 10/18/2022] Open
|
16
|
Martínez-Sánchez D, Romero-Maté A, Romero-Figueroa K, Borbujo J. Unilateral livedo reticularis after kidney graft embolization with polyvinyl alcohol microspheres. Br J Dermatol 2011; 164:1400-2. [PMID: 21332466 DOI: 10.1111/j.1365-2133.2011.10256.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
17
|
Sanz-Sánchez T, Romero-Maté A, Tardío JC, Donoso MCG, Córdoba S, Borbujo J. Acantholytic dermatosis in psoriatic patient with methotrexate toxicity. J Eur Acad Dermatol Venereol 2008; 22:1236-7. [DOI: 10.1111/j.1468-3083.2007.02551.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
18
|
Hernández-Núñez A, Tardío JC, Castellano-Megias VM, Romero-Maté A, Borbujo J. Nuchal-type fibroma associated with lipoma and traumatic neuroma. J Eur Acad Dermatol Venereol 2008; 21:1420-2. [PMID: 17958856 DOI: 10.1111/j.1468-3083.2007.02223.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|